58 Biggest Movers From Yesterday
Gainers
Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 234.2% to close at $1.27 after the company announced it sold its complement portfolio for $60 million.
30 Stocks Moving In Monday’s Mid-Day Session
Gainers
Evolve Transition Infrastructure LP (NYSE: SNMP) shares rose 29.2% to $0.6699 after jumping around 14% on Friday.
Repare Therapeutics Shares Dip After Updated RP-3500 Data In Solid Tumors
Repare Therapeutics Inc (NASDAQ:RPTX) presented updated data from its ongoing Phase 1/2 TRESR trial of RP-3500 for solid tumors with specific…
Stifel Downgrades Repare Therapeutics to Hold, Lowers Price Target to $11
Stifel analyst Benjamin Burnett downgrades Repare Therapeutics (NASDAQ:RPTX) from Buy to Hold and lowers the price target from $45 to $11.
Repare Therapeutics Highlights Presentation Of Updated Data From Ongoing Phase 1/2 Study Of Its RP-3500 Monotherapy In Solid Tumors At American Association For Cancer Research
RP-3500 shows robust activity in ovarian cancer demonstrating 75% CBR, with 25% ORR and mPFS of 35 weeks
Updated monotherapy results show 43% CBR in solid tumors across genotypes, and potential best-in-class safety and
Repare Therapeutics Highlights Early RP-3500 Data In Solid Tumor Patients
Repare Therapeutics Inc (NASDAQ: RPTX) has announced the presentation of
Repare Therapeutics Presents RP-3500 Dose Selection Phase 1 Monotherapy Safety Data From The Phase 1/2 TRESR Clinical Trial At The 2022 ESMO Targeted Anticancer Therapies Congress
Repare Therapeutics Inc. (“Repare” or the “Company”) (NASDAQ:RPTX), a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and
Repare Therapeutics Q4 EPS $(0.70) Down From $(0.41) YoY
Repare Therapeutics (NASDAQ:RPTX) reported quarterly losses of $(0.70) per share. This is a 70.73 percent decrease over losses of $(0.41) per share from the same period last year.